A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents. [electronic resource]
Producer: 20171004Description: 507-12 p. digitalISSN:- 1879-0518
- Adolescent
- Child
- Contraceptive Agents, Female -- administration & dosage
- Device Removal -- statistics & numerical data
- Europe
- Female
- Humans
- Intrauterine Devices, Medicated -- adverse effects
- Levonorgestrel -- administration & dosage
- Parity
- Patient Satisfaction
- Pelvic Inflammatory Disease -- etiology
- Pregnancy
- Pregnancy, Ectopic -- etiology
- Pregnancy, Unplanned
- Uterine Perforation -- etiology
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.